According to a Yahoo poster, it is an error. It is IMUR who is
'pondering" merging.
However, Immune Response received a patent yesterday
for Remune.
The NDA for Remune in Thailand is supposed to be is supposed to be submitted in a few days, according to some Yahoo posters, fwiw.
Interesting, though, how the shorts panic at any news, real or not.
164.195.100.11
United States Patent 5,928,930
Salk , et al. July 27, 1999
--------------------------------------------------------------------------------
Prevention and treatment of retroviral disease
Abstract
The present invention provides a non-infectious immunotherapeutic containing retroviral particles devoid of outer envelope proteins or containing selected antigens isolated from a retrovirus. There is also provided a vaccine effective against HIV. In one aspect, the immunogen is useful for immunizing an individual previously infected by a retrovirus including HIV, so as to induce immunoprotective factors protective against progression of the infection. In another aspect, the vaccine is useful for vaccinating an individual not previously infected with HIV in order to prevent subsequently acquired infection. In another aspect, there is provided a method of rendering a viral immunogen non-infectious. The immunogen may also be used to produce antibodies for passive immunotherapy, alone or in conjunction with active immunotherapy, in individuals infected with a retrovirus, including HIV, preferably those individuals exhibiting low levels of antibodies to retroviral gene products other than the outer envelope. |
